Avadel Pharmaceuticals plc announced the addition of Gregory J. Divis as Executive Vice President and Chief Commercial Officer, a newly created role at the company. Divis brings more than 25 years of experience in the pharmaceutical industry to the role and will be responsible for managing commercial strategy and execution across all of the Company's portfolio products. Divis served as President and Chief Executive Officer of Lumara Health. Divis has also held such notable roles as Vice-President, Business Development & Lifecycle Management at Sanofi-Aventis and as Vice-President and General Manager, UK and Ireland, for Schering-Plough Corporation.